Harold Smith, PA

NPI: 1174590590
Total Payments
$24,876
2024 Payments
$155.88
Companies
7
Transactions
56
Medicare Patients
492
Medicare Billing
$31,572

Payment Breakdown by Category

Other$20,350 (81.8%)
Travel$3,402 (13.7%)
Food & Beverage$1,124 (4.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20,350 16 81.8%
Travel and Lodging $3,402 18 13.7%
Food and Beverage $1,124 22 4.5%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $23,406 42 $0 (2022)
Bayer Healthcare Pharmaceuticals Inc. $1,033 9 $0 (2023)
Averitas Pharma Inc. $155.88 1 $0 (2024)
Novo Nordisk Inc $124.99 1 $0 (2023)
Neurocrine Biosciences, Inc. $121.81 1 $0 (2022)
Siemens Medical Solutions USA, Inc. $19.74 1 $0 (2022)
AstraZeneca Pharmaceuticals LP $14.23 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $155.88 1 Averitas Pharma Inc. ($155.88)
2023 $1,142 9 Bayer Healthcare Pharmaceuticals Inc. ($1,017)
2022 $280.16 4 ABBVIE INC. ($122.03)
2021 $23,298 42 AbbVie Inc. ($23,284)

All Payment Transactions

56 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
10/16/2024 Averitas Pharma Inc. QUTENZA (Drug) Food and Beverage In-kind items and services $155.88 General
Category: PAIN MANAGEMENT
07/07/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $13.78 General
Category: Cardio-renal
06/03/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Travel and Lodging In-kind items and services $502.30 General
Category: Cardio-renal
06/03/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Travel and Lodging In-kind items and services $183.91 General
Category: Cardio-renal
06/03/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $91.38 General
Category: Cardio-renal
06/03/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $82.30 General
Category: Cardio-renal
06/03/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $61.18 General
Category: Cardio-renal
06/03/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $48.36 General
Category: Cardio-renal
06/03/2023 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $33.60 General
Category: Cardio-renal
04/05/2023 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Obesity
12/13/2022 Siemens Medical Solutions USA, Inc. Food and Beverage In-kind items and services $19.74 General
12/05/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $16.58 General
Category: Cardio-renal
08/17/2022 Neurocrine Biosciences, Inc. INGREZZA (Drug), Ongentys Food and Beverage In-kind items and services $121.81 General
Category: Neuropsychiatry
06/15/2022 ABBVIE INC. Food and Beverage In-kind items and services $122.03 General
09/28/2021 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $295.30 General
Category: NEUROSCIENCE
09/28/2021 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $161.17 General
Category: NEUROSCIENCE
09/28/2021 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $159.55 General
Category: NEUROSCIENCE
09/28/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage Cash or cash equivalent $35.69 General
Category: NEUROSCIENCE
09/20/2021 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,375.00 General
Category: NEUROSCIENCE
09/20/2021 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $97.44 General
Category: NEUROSCIENCE
08/23/2021 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,650.00 General
Category: NEUROSCIENCE
08/23/2021 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $134.40 General
Category: NEUROSCIENCE
08/06/2021 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,650.00 General
Category: NEUROSCIENCE
08/05/2021 AbbVie Inc. VRAYLAR (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,650.00 General
Category: NEUROSCIENCE
08/05/2021 AbbVie Inc. VRAYLAR (Drug) Travel and Lodging In-kind items and services $295.30 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 78 118 $29,534 $6,345
2022 3 96 149 $34,139 $6,342
2021 5 142 223 $33,864 $10,540
2020 5 176 257 $35,760 $8,346
Total Patients
492
Total Services
747
Medicare Billing
$31,572
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 51 82 $25,420 $5,425 21.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 14 $3,080 $710.16 23.1%
83036 Hemoglobin a1c level Office 2023 14 22 $1,034 $209.44 20.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 44 70 $21,210 $3,803 17.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 38 55 $11,825 $2,308 19.5%
83036 Hemoglobin a1c level Office 2022 14 24 $1,104 $230.64 20.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 48 81 $18,630 $5,239 28.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 55 84 $12,768 $4,546 35.6%
83036 Hemoglobin a1c level Office 2021 17 36 $1,476 $349.56 23.7%
90686 Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free Office 2021 11 11 $440.00 $225.83 51.3%
G0008 Administration of influenza virus vaccine Office 2021 11 11 $550.00 $178.86 32.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 58 87 $19,575 $4,424 22.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 46 68 $10,132 $2,477 24.4%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 18 26 $3,958 $1,012 25.6%
83036 Hemoglobin a1c level Office 2020 17 31 $1,240 $299.30 24.1%
36415 Insertion of needle into vein for collection of blood sample Office 2020 37 45 $855.00 $134.04 15.7%

About Harold Smith, PA

Harold Smith, PA is a Physician Assistant healthcare provider based in Concord, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174590590.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Harold Smith, PA has received a total of $24,876 in payments from pharmaceutical and medical device companies, with $155.88 received in 2024. These payments were reported across 56 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($20,350).

As a Medicare-enrolled provider, Smith has provided services to 492 Medicare beneficiaries, totaling 747 services with total Medicare billing of $31,572. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Concord, NC
  • Active Since 03/03/2006
  • Last Updated 07/15/2024
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1174590590

Products in Payments

  • VRAYLAR (Drug) $23,284
  • Kerendia (Drug) $1,033
  • QUTENZA (Drug) $155.88
  • Wegovy (Drug) $124.99
  • INGREZZA (Drug) $121.81

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Concord